Nifty

:

18606.65

Sensex

:

62972.85

8.00 (0.04%)
126.47 (0.20%)

Login

Nifty
Sensex

:
:

18606.65
62972.85

8.00 (0.04%)
126.47 (0.20%)

Gufic Biosciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

68/99

BSE: 509079 | NSE: GUFICBIO

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,045.04
24.98
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,079.72
0.05%
6.20

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

22.77
20.59
27.17

EBITDA CAGR (%)

10 Years
5 Years
3 Years

29.79
30.31
22.83

PAT CAGR (%)

10 Years
5 Years
3 Years

39.93
42.21
61.65

P:E (Median)

8 Years
5 Years
3 Years

35.62
26.56
26.24

P:BV (Average)

8 Years
5 Years
3 Years

7.87
7.87
8.14

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.89
16.23
17.09

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 177.47 172.06 3.14% 174.83 194.14 -9.95% 165.28 250.76 -34.09% 162.19 131.93 22.94%
Expenses 144.08 139.35 3.39% 142.22 158.31 -10.16% 132.10 205.11 -35.60% 130.67 108.18 20.79%
EBITDA 33.39 32.72 2.05% 32.61 35.83 -8.99% 33.18 45.65 -27.32% 31.52 23.75 32.72%
EBIDTM 18.82% 19.02% 18.65% 18.46% 20.07% 18.20% 19.43% 18.00%
Other Income 0.76 1.53 -50.33% 0.82 0.31 164.52% 0.38 1.23 -69.11% 0.04 0.66 -93.94%
Interest 2.16 1.03 109.71% 1.61 1.55 3.87% 0.91 1.21 -24.79% 1.06 2.87 -63.07%
Depreciation 4.74 4.48 5.80% 4.56 4.20 8.57% 4.37 4.13 5.81% 4.33 4.48 -3.35%
PBT 27.25 28.73 -5.15% 27.26 30.39 -10.30% 28.28 41.54 -31.92% 26.18 17.05 53.55%
Tax 6.91 7.70 -10.26% 7.05 7.05 0.00% 7.23 10.33 -30.01% 5.91 4.18 41.39%
PAT 20.34 21.03 -3.28% 20.21 23.34 -13.41% 21.05 31.21 -32.55% 20.27 12.87 57.50%
PATM 11.46% 12.22% 11.56% 12.02% 12.74% 12.45% 12.49% 9.76%
EPS 2.10 2.17 -3.23% 2.09 2.41 -13.28% 2.17 3.22 -32.61% 2.09 1.33 57.14%

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 679.77 779.16 487.70 378.84 350.77 305.58 245.52 202.20 151.55 123.01 100.14 Net Sales Growth -9.23% 59.76% 28.74% 8.00% 14.79% 24.46% 21.42% 33.42% 23.20% 22.84% Cost Of Goods Sold 320.73 368.49 226.12 156.47 161.37 128.58 107.42 90.84 73.47 55.61 46.05 Gross Profit 359.04 410.67 261.58 222.37 189.40 177.01 138.10 111.35 78.08 67.40 54.09 GP Margin 52.82% 52.71% 53.64% 58.70% 54.00% 57.93% 56.25% 55.07% 51.52% 54.79% 54.01% Total Expenditure 549.07 633.44 403.78 326.72 304.78 266.80 222.57 182.51 137.28 110.98 89.40 Power & Fuel Cost - 11.00 9.94 8.23 3.43 3.58 3.51 3.57 3.16 2.95 3.21 % Of Sales - 1.41% 2.04% 2.17% 0.98% 1.17% 1.43% 1.77% 2.09% 2.40% 3.21% Employee Cost - 85.61 66.22 58.59 46.85 44.62 41.03 31.95 19.23 12.25 5.45 % Of Sales - 10.99% 13.58% 15.47% 13.36% 14.60% 16.71% 15.80% 12.69% 9.96% 5.44% Manufacturing Exp. - 82.14 46.74 43.26 43.16 37.69 28.94 23.54 15.48 17.33 9.14 % Of Sales - 10.54% 9.58% 11.42% 12.30% 12.33% 11.79% 11.64% 10.21% 14.09% 9.13% General & Admin Exp. - 38.12 23.69 32.47 32.32 31.50 27.03 20.56 13.56 8.82 3.79 % Of Sales - 4.89% 4.86% 8.57% 9.21% 10.31% 11.01% 10.17% 8.95% 7.17% 3.78% Selling & Distn. Exp. - 28.38 17.87 17.35 11.36 13.26 9.11 8.19 8.78 12.41 19.92 % Of Sales - 3.64% 3.66% 4.58% 3.24% 4.34% 3.71% 4.05% 5.79% 10.09% 19.89% Miscellaneous Exp. - 19.70 13.20 10.36 6.29 7.57 5.53 3.85 3.61 1.61 19.92 % Of Sales - 2.53% 2.71% 2.73% 1.79% 2.48% 2.25% 1.90% 2.38% 1.31% 1.84% EBITDA 130.70 145.72 83.92 52.12 45.99 38.78 22.95 19.69 14.27 12.03 10.74 EBITDA Margin 19.23% 18.70% 17.21% 13.76% 13.11% 12.69% 9.35% 9.74% 9.42% 9.78% 10.72% Other Income 2.00 3.10 3.73 5.79 4.17 2.86 1.44 0.66 0.57 0.63 0.39 Interest 5.74 4.85 13.63 13.91 10.16 8.88 6.34 6.20 4.46 3.92 3.69 Depreciation 18.00 17.13 16.31 13.86 4.65 4.40 3.68 3.79 3.85 2.47 2.18 PBT 108.97 126.84 57.71 30.13 35.35 28.37 14.37 10.36 6.53 6.27 5.26 Tax 27.10 31.00 13.48 7.44 13.41 13.48 5.35 3.03 2.37 2.01 1.93 Tax Rate 24.87% 24.44% 23.36% 24.69% 37.93% 44.99% 37.23% 29.25% 36.29% 32.06% 36.69% PAT 81.87 95.84 44.23 22.69 21.94 16.48 9.02 7.32 4.16 4.26 3.33 PAT before Minority Interest 81.87 95.84 44.23 22.69 21.94 16.48 9.02 7.32 4.16 4.26 3.33 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.04% 12.30% 9.07% 5.99% 6.25% 5.39% 3.67% 3.62% 2.74% 3.46% 3.33% PAT Growth -7.44% 116.69% 94.93% 3.42% 33.13% 82.71% 23.22% 75.96% -2.35% 27.93% EPS 8.45 9.89 4.56 2.34 2.26 1.70 0.93 0.76 0.43 0.44 0.34

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 269.12 173.44 129.32 75.35 54.14 37.33 33.96 27.10 26.21 22.39 Share Capital 9.69 9.69 9.69 7.78 7.78 7.74 7.74 7.74 7.74 7.74 Total Reserves 259.42 163.74 119.63 67.56 46.35 29.59 26.22 19.36 18.47 14.66 Non-Current Liabilities 65.30 54.96 37.79 17.16 12.54 9.16 14.56 16.58 24.63 23.53 Secured Loans 47.40 35.43 19.52 11.25 4.43 3.20 4.84 8.62 10.17 13.72 Unsecured Loans 0.00 0.00 0.03 0.06 3.89 3.42 2.82 2.88 4.71 4.72 Long Term Provisions 12.39 10.23 7.93 1.86 2.26 2.29 1.39 1.41 1.35 1.19 Current Liabilities 186.98 163.66 325.60 217.72 168.55 128.18 103.68 83.61 60.31 43.65 Trade Payables 140.95 111.21 117.07 77.81 75.98 43.74 52.62 49.53 31.80 20.14 Other Current Liabilities 33.89 29.98 22.99 16.28 17.24 20.75 14.10 13.01 11.28 7.74 Short Term Borrowings 6.60 16.32 93.10 84.69 69.17 46.97 32.28 17.90 14.77 13.74 Short Term Provisions 5.55 6.15 92.44 38.95 6.16 16.73 4.67 3.16 2.47 2.04 Total Liabilities 521.40 392.06 492.71 310.23 235.23 174.67 152.20 127.29 111.15 89.57 Net Block 115.17 99.97 82.58 24.45 22.85 21.96 22.15 25.11 30.23 26.83 Gross Block 177.85 148.64 114.98 37.19 31.00 25.65 51.31 50.81 48.46 42.59 Accumulated Depreciation 62.69 48.67 32.40 12.74 8.15 3.68 29.17 25.71 18.23 15.76 Non Current Assets 200.65 131.48 133.58 46.34 37.02 31.42 32.69 35.81 41.84 39.36 Capital Work in Progress 40.87 13.40 30.61 9.63 2.05 0.04 0.00 0.00 0.00 2.98 Non Current Investment 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 43.65 17.12 18.54 10.16 8.73 7.60 9.01 9.17 11.32 7.34 Other Non Current Assets 0.95 0.98 1.84 2.09 3.38 1.82 1.52 1.52 0.28 2.20 Current Assets 320.75 260.58 359.13 263.89 198.20 143.25 119.51 91.48 69.30 50.22 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 115.57 94.40 122.46 94.28 94.20 63.02 50.26 36.80 26.12 20.00 Sundry Debtors 151.55 124.50 106.97 103.18 80.80 52.12 56.23 33.38 28.21 20.01 Cash & Bank 26.57 13.18 16.37 7.59 7.50 5.64 6.16 6.21 2.54 1.28 Other Current Assets 27.07 0.69 0.84 1.10 15.71 22.47 6.86 15.08 12.44 8.93 Short Term Loans & Adv. 26.21 27.81 112.48 57.74 15.33 21.38 6.10 12.45 9.60 7.19 Net Current Assets 133.77 96.92 33.53 46.17 29.66 15.07 15.84 7.87 8.99 6.57 Total Assets 521.40 392.06 492.71 310.23 235.22 174.67 152.20 127.29 111.14 89.58

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 104.44 87.25 47.10 5.21 -4.82 -4.13 -4.32 11.15 10.87 5.26 PBT 126.84 57.71 30.13 35.35 29.95 14.37 11.19 6.53 6.27 5.26 Adjustment 20.86 30.79 24.63 13.35 12.07 9.75 8.84 8.19 6.27 5.95 Changes in Working Capital -10.20 8.15 2.48 -33.52 -30.40 -23.70 -21.31 -1.60 -0.19 -4.42 Cash after chg. in Working capital 137.50 96.65 57.24 15.18 11.63 0.42 -1.28 13.12 12.36 6.79 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -33.06 -9.40 -10.14 -9.98 -16.44 -4.55 -2.65 -1.96 -1.49 -1.54 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 0.00 0.00 0.00 Cash From Investing Activity -95.94 -6.69 -42.53 -12.99 -8.84 -4.69 -0.51 -2.39 -2.78 -13.26 Net Fixed Assets -56.68 -16.45 -98.77 -13.77 -7.36 25.62 -0.50 -2.35 -2.89 -12.90 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -39.26 9.76 56.24 0.78 -1.48 -30.31 -0.01 -0.04 0.11 -0.36 Cash from Financing Activity -3.10 -78.62 -4.21 7.71 14.40 7.41 4.78 -5.09 -6.82 8.32 Net Cash Inflow / Outflow 5.41 1.94 0.37 -0.08 0.75 -1.41 -0.05 3.67 1.26 0.32 Opening Cash & Equivalents 6.20 4.26 3.90 3.74 2.99 4.28 6.21 2.54 1.28 0.96 Closing Cash & Equivalent 11.61 6.20 4.26 3.66 3.74 2.87 6.16 6.21 2.54 1.28

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 27.76 17.89 13.34 9.68 6.96 4.83 4.39 3.50 3.39 2.90 ROA 20.98% 10.00% 5.65% 8.04% 8.04% 5.52% 5.24% 3.49% 4.25% 4.04% ROE 43.31% 29.22% 22.17% 33.89% 36.03% 25.31% 23.99% 15.60% 17.55% 15.89% ROCE 47.10% 30.05% 21.01% 29.65% 34.10% 24.26% 24.24% 18.38% 17.45% 18.44% Fixed Asset Turnover 5.20 3.94 5.14 10.57 11.21 6.77 4.19 3.22 2.86 2.85 Receivable days 59.40 81.43 97.98 93.16 76.39 75.93 76.38 70.29 67.55 73.52 Inventory Days 45.18 76.30 101.05 95.44 90.36 79.39 74.21 71.80 64.60 63.71 Payable days 124.89 184.25 115.05 115.32 80.93 87.99 110.87 119.47 95.34 87.64 Cash Conversion Cycle -20.30 -26.52 83.98 73.27 85.82 67.32 39.73 22.62 36.81 49.59 Total Debt/Equity 0.23 0.32 0.90 1.30 1.47 1.52 1.26 1.21 1.27 1.55 Interest Cover 27.17 5.23 3.17 4.48 4.37 3.27 2.67 2.46 2.60 2.43

Top Investors:

jagdish n master

sbi healthcare opportunities fund

girish gulati huf

investor education and protection fund (iepf)

Annual Reports:

News Update:

Gufic Biosciences incorporates wholly owned subsidiary in Ireland
4th Mar 2023, 16:31 PM

The incorporation of Gufic Ireland would give vast business exposure to the Company in European market
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback